Lu Yan Pharmaceuticals: Stock trading experienced abnormal fluctuations, there are no undisclosed matters that should have been disclosed.

Lu Yan Pharmaceuticals announced that the company's stock price deviated by more than 20% from the closing price for three consecutive trading days from July 14 to July 16, 2026, which is considered abnormal fluctuation. After verification, it was found that there is no need to amend or supplement the company's previous disclosure information, the operating and internal/external environments are normal, no undisclosed significant information reported by the public media was found, and there are no undisclosed significant matters regarding the company, controlling shareholders, or actual controllers. During the abnormal fluctuation period, the controlling shareholders and actual controllers did not buy or sell the company's stock, and there is no violation of fair disclosure of information. The company does not need to disclose the performance forecast for the first half of 2026. Investors are reminded to invest rationally and to pay attention to risks.